TB-403: Phase I/IIa started

Oncurious and BioInvent began an open-label, U.S. Phase I/IIa of IV TB-403 in >=27

Read the full 149 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE